{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T13:19:18Z","timestamp":1648732758319},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12957-018-1389-3","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T04:23:57Z","timestamp":1524716637000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Anna","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin P.","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel M.","family":"Baumgartner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Lowy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlyn J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol"},{"key":"1389_CR2","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ejso.2010.01.006","volume":"36","author":"D Elias","year":"2010","unstructured":"Elias D, Gilly F, Quenet F, Bereder JM, Sideris L, Mansvelt B, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36:456\u201362.","journal-title":"Eur J Surg Oncol"},{"key":"1389_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jamcollsurg.2013.12.013","volume":"218","author":"EA Levine","year":"2014","unstructured":"Levine EA, Stewart JH 4th, Shen P, Russell GB, Loggie BL, Votanopoulos KI. Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. J Am Coll Surg. 2014;218:573\u201385.","journal-title":"J Am Coll Surg"},{"key":"1389_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ejso.2014.08.476","volume":"41","author":"AC Lord","year":"2015","unstructured":"Lord AC, Shihab O, Chandrakumaran K, Mohamed F, Cecil TD, Moran BJ. Recurrence and outcome after complete tumour removal and hyperthermic intraperitoneal chemotherapy in 512 patients with pseudomyxoma peritonei from perforated appendiceal mucinous tumours. Eur J Surg Oncol. 2015;41:396\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s11605-014-2477-5","volume":"18","author":"P Tabrizian","year":"2014","unstructured":"Tabrizian P, Shrager B, Jibara G, Yang MJ, Romanoff A, Hiotis S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: outcomes from a single tertiary institution. J Gastrointest Surg. 2014;18:1024\u201331.","journal-title":"J Gastrointest Surg"},{"key":"1389_CR6","first-page":"639","volume":"23","author":"M Vaira","year":"2009","unstructured":"Vaira M, Cioppa T, De Marco G, Bing C, D'Amico S, D'Alessandro M, et al. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience. In Vivo. 2009;23:639\u201344.","journal-title":"In Vivo"},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1245\/s10434-015-5012-3","volume":"23","author":"JM Baumgartner","year":"2016","unstructured":"Baumgartner JM, Kwong TG, Ma GL, Messer K, Kelly KJ, Lowy AM. A novel tool for predicting major complications after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2016;23:1609\u201317.","journal-title":"Ann Surg Oncol"},{"key":"1389_CR8","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/S1055-3207(03)00051-6","volume":"12","author":"DM Elias","year":"2003","unstructured":"Elias DM, Sideris L. Pharmacokinetics of heated intraoperative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis. Surg Oncol Clin N Am. 2003;12:755\u201369. xiv","journal-title":"Surg Oncol Clin N Am"},{"key":"1389_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/378064","volume":"2012","author":"K Van der Speeten","year":"2012","unstructured":"Van der Speeten K, Govaerts K, Stuart OA, Sugarbaker PH. Pharmacokinetics of the perioperative use of cancer chemotherapy in peritoneal surface malignancy patients. Gastroenterol Res Pract. 2012;2012:378064. \n                    https:\/\/doi.org\/10.1155\/2012\/378064\n                    \n                  .","journal-title":"Gastroenterol Res Pract"},{"key":"1389_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1055-3207(03)00034-6","volume":"12","author":"MH Katz","year":"2003","unstructured":"Katz MH, Barone RM. The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am. 2003;12:673\u201388.","journal-title":"Surg Oncol Clin N Am"},{"key":"1389_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.bpg.2012.01.010","volume":"26","author":"B de Goede","year":"2012","unstructured":"de Goede B, Klitsie PJ, Lange JF, Metselaar HJ, Kazemier G. Morbidity and mortality related to non-hepatic surgery in patients with liver cirrhosis: a systematic review. Best Pract Res Clin Gastroenterol. 2012;26:47\u201359.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"7129","DOI":"10.3748\/wjg.v19.i41.7129","volume":"19","author":"A El Nakeeb","year":"2013","unstructured":"El Nakeeb A, Sultan AM, Salah T, El Hemaly M, Hamdy E, Salem A, et al. Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy. World J Gastroenterol. 2013;19:7129\u201337.","journal-title":"World J Gastroenterol"},{"key":"1389_CR13","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1053\/j.gastro.2007.01.040","volume":"132","author":"SH Teh","year":"2007","unstructured":"Teh SH, Nagorney DM, Stevens SR, Offord KP, Therneau TM, Plevak DJ, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132:1261\u20139.","journal-title":"Gastroenterology"},{"key":"1389_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187\u201396.","journal-title":"Ann Surg"},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.ejso.2006.03.012","volume":"32","author":"PH Sugarbaker","year":"2006","unstructured":"Sugarbaker PH, Yan TD, Stuart OA, Yoo D. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006;32:686\u201391.","journal-title":"Eur J Surg Oncol"},{"key":"1389_CR16","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1245\/s10434-014-3807-2","volume":"21","author":"PM Polanco","year":"2014","unstructured":"Polanco PM, Sanchez AI, Ramalingam L, Jones H, Zureikat A, Holtzman M, et al. Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms? Ann Surg Oncol. 2014;21:3963\u20139.","journal-title":"Ann Surg Oncol"},{"key":"1389_CR17","doi-asserted-by":"publisher","first-page":"e84","DOI":"10.3747\/co.v18i2.663","volume":"18","author":"F Mohamed","year":"2011","unstructured":"Mohamed F, Cecil T, Moran B, Sugarbaker P. A new standard of care for the management of peritoneal surface malignancy. Curr Oncol. 2011;18:e84\u201396.","journal-title":"Curr Oncol"},{"issue":"24","key":"1389_CR18","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1200\/JCO.2006.07.1142","volume":"24","author":"TD Yan","year":"2006","unstructured":"Yan TD, Black D, Savady R, Sugarbaker PH. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24(24):4011\u20139.","journal-title":"J Clin Oncol"},{"key":"1389_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1245\/s10434-006-9182-x","volume":"14","author":"TD Yan","year":"2007","unstructured":"Yan TD, Black D, Savady R, Sugarbaker PH. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei. Ann Surg Oncol. 2007;14:484\u201392.","journal-title":"Ann Surg Oncol"},{"key":"1389_CR20","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.soc.2012.07.013","volume":"21","author":"K Van der Speeten","year":"2012","unstructured":"Van der Speeten K, Stuart OA, Sugarbaker PH. Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy. Surg Oncol Clin N Am. 2012;21:577\u201397.","journal-title":"Surg Oncol Clin N Am"},{"issue":"Suppl 5","key":"1389_CR21","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1245\/s10434-016-5519-2","volume":"23","author":"M Alyami","year":"2016","unstructured":"Alyami M, Lundberg P, Kepenekian V, Goere D, Bereder JM, Msika S, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in the elderly: a case-controlled, multicenter study. Ann Surg Oncol. 2016;23(Suppl 5):737\u201345.","journal-title":"Ann Surg Oncol"},{"key":"1389_CR22","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1002\/jso.24366","volume":"114","author":"MG Neuwirth","year":"2016","unstructured":"Neuwirth MG, Bartlett EK, Roses RE, Fraker DL, Kelz RR, Karakousis GC. Obesity is not associated with increased morbidity in patients undergoing cytoreductive surgery with intraperitoneal chemotherapy. J Surg Oncol. 2016;114:619\u201324.","journal-title":"J Surg Oncol"},{"key":"1389_CR23","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.suronc.2013.06.001","volume":"22","author":"P Tabrizian","year":"2013","unstructured":"Tabrizian P, Jibara G, Shrager B, Franssen B, Yang MJ, Sarpel U, et al. Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly. Surg Oncol. 2013;22:184\u20139.","journal-title":"Surg Oncol"},{"key":"1389_CR24","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1245\/s10434-013-3087-2","volume":"20","author":"KI Votanopoulos","year":"2013","unstructured":"Votanopoulos KI, Swords DS, Swett KR, Randle RW, Shen P, Stewart JH, et al. Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors. Ann Surg Oncol. 2013;20:3899\u2013904.","journal-title":"Ann Surg Oncol"},{"key":"1389_CR25","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S1055-3207(03)00030-9","volume":"12","author":"CR Rossi","year":"2003","unstructured":"Rossi CR, Mocellin S, Pilati P, Foletto M, Quintieri L, Palatini P, et al. Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surg Oncol Clin N Am. 2003;12:781\u201394.","journal-title":"Surg Oncol Clin N Am"},{"key":"1389_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jso.23449","volume":"109","author":"KJ Kelly","year":"2014","unstructured":"Kelly KJ, Nash GM. Peritoneal debulking\/intraperitoneal chemotherapy-non-sarcoma. J Surg Oncol. 2014;109:14\u201322.","journal-title":"J Surg Oncol"},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1245\/s10434-014-3985-y","volume":"22","author":"JM Baumgartner","year":"2015","unstructured":"Baumgartner JM, Tobin L, Heavey SF, Kelly KJ, Roeland EJ, Lowy AM. Predictors of progression in high-grade appendiceal or colorectal peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2015;22:1716\u201321.","journal-title":"Ann Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12957-018-1389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-018-1389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T19:16:41Z","timestamp":1556219801000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-018-1389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1186\/s12957-018-1389-3","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"11 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The creation of the REDCap database for all HIPEC patients seen at UCSD operates under UCSD Institutional Review Board approval. Patients are consented at the time of presentation to UCSD for inclusion. The IRB approval number is 140754.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"87"}}